Federal Circuit Finds Diagnostic Test for Down Syndrome Not Patent-Eligible
A method to assess the risk of fetal Down's syndrome is not patent-eligible subject matter, the U.S. Court of Appeals for the Federal Circuit has ruled, relying on recent high-profile cases about medical diagnostic patents.
By Sheri Qualters|November 21, 2012
Thank you for sharing!
Your article was successfully shared with the contacts you provided.
As part of your digital membership, you can sign up for an unlimited number of a wide range of complimentary newsletters.
Visit your My Account page to make your selections. Get the timely legal news and critical analysis you cannot afford to miss.
Tailored just for you. In your inbox. Every day.